Roche Posts Double-Digit Increase in Full-Year Applied Science Revenues, Dip in MDx | GenomeWeb

NEW YORK (GenomeWeb News) – Roche today reported a 3 percent increase in full-year revenues for its diagnostics division, to 9.7 billion Swiss francs ($8.4 billion) from 9.4 billion Swiss francs ($8.1 billion) in 2007.

The diagnostics division includes several business areas, including molecular diagnostics, which posted a 2 percent dip in revenues, to 1.1 billion Swiss francs, and applied sciences, which recorded an 11 percent increase in sales, to 765 million Swiss francs.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: genes involved in histone deacetylation in Arabidopsis, effects of pathogenic presenilin-1 mutations, and more.

After a study finds DNA from antibiotic-resistant bacteria in Beijing smog, residents there worry, according to the New York Times.

Canada begins its search for a chief government science advisor, Nature News reports.

A company is using facial recognition tools to identify genetic disorders from pictures, Technology Review reports.